Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Trius Therapeutics Inc (TSRX) Create: Alert

All | News | Filings
Date FiledTypeDescription
09/11/2013 8-K Quarterly results
08/06/2013 8-K Quarterly results
Docs: "TRIUS THERAPEUTICS REPORTS SECOND QUARTER 2013 FINANCIAL RESULTS"
07/25/2013 8-K Entry into a Material Definitive Agreement
05/07/2013 8-K Quarterly results
Docs: "TRIUS THERAPEUTICS REPORTS FIRST QUARTER 2013 FINANCIAL RESULTS"
03/25/2013 8-K Other Events, Financial Statements and Exhibits
Docs: "TRIUS ANNOUNCES POSITIVE RESULTS FROM ESTABLISH 2 STUDY OF TEDIZOLID IN SEVERE SKIN INFECTIONS",
"Trius Therapeutics, Inc. Presentation"
03/13/2013 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
03/12/2013 8-K Quarterly results
Docs: "TRIUS THERAPEUTICS REPORTS 2012 FOURTH QUARTER AND FULL YEAR 2012 FINANCIAL RESULTS"
01/18/2013 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits
Docs: "Underwriting Agreement",
"Opinion of Cooley LLP",
"TRIUS THERAPEUTICS, INC. ANNOUNCES PROPOSED PUBLIC OFFERING OF COMMON STOCK",
"TRIUS THERAPEUTICS, INC. PRICES PUBLIC OFFERING OF COMMON STOCK"
01/07/2013 8-K Results of Operations and Financial Condition, Other Events, Financial Statements and Exhibits
Docs: "TEDIZOLID RECEIVES QUALIFIED INFECTIOUS DISEASE PRODUCT DESIGNATION FROM FDA"
11/05/2012 8-K Quarterly results
Docs: "TRIUS THERAPEUTICS REPORTS 2012 THIRD QUARTER FINANCIAL RESULTS"
10/09/2012 8-K Form 8-K - Current report
08/31/2012 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits
Docs: "Common Stock Purchase Agreement between Trius Therapeutics, Inc. and Terrapin Opportunity, L.P.",
"TRIUS THERAPEUTICS SECURES A $25 MILLION COMMITTED EQUITY FINANCING FACILITY WITH TERRAPIN OPPORTUNITY, L.P."
08/06/2012 8-K Quarterly results
Docs: "TRIUS THERAPEUTICS REPORTS 2012 SECOND QUARTER FINANCIAL RESULTS"
05/23/2012 8-K Form 8-K - Current report
05/08/2012 8-K Quarterly results
Docs: "TRIUS THERAPEUTICS REPORTS FIRST QUARTER 2012 FINANCIAL RESULTS"
04/12/2012 8-K Form 8-K - Current report
03/13/2012 8-K Form 8-K - Current report
01/26/2012 8-K Form 8-K - Current report
01/25/2012 8-K Other Events
01/03/2012 8-K Other Events, Financial Statements and Exhibits
Docs: "Slide presentation"
12/20/2011 8-K Form 8-K - Current report
12/19/2011 8-K Other Events, Financial Statements and Exhibits
Docs: "TRIUS REPORTS POSITIVE RESULTS FROM FIRST PHASE 3 TRIAL OF TEDIZOLID IN ACUTE BACTERIAL SKIN AND SKIN STRUCTURE INFECTIONS"
11/10/2011 8-K Form 8-K - Current report
08/17/2011 8-K Form 8-K - Current report
08/11/2011 8-K Form 8-K - Current report
08/05/2011 8-K Other Events, Financial Statements and Exhibits
Docs: "TRIUS THERAPEUTICS OBTAINS SPECIAL PROTOCOL ASSESSMENT WITH FDA FOR SECOND PHASE 3 STUDY OF TOREZOLID PHOSPHATE"
07/27/2011 8-K Entry into a Material Definitive Agreement, Results of Operations and Financial Condition, Financial Statements and Exhibits
Docs: "TRIUS THERAPEUTICS AND BAYER FORM STRATEGIC COLLABORATION TO DEVELOP AND COMMERCIALIZE TOREZOLID PHOSPHATE IN ASIA-PACIFIC AND EMERGING MARKETS"
06/03/2011 8-K Submission of Matters to a Vote of Security Holders
05/25/2011 8-K Form 8-K - Current report
05/05/2011 8-K Form 8-K - Current report
03/23/2011 8-K Quarterly results
Docs: "TRIUS THERAPEUTICS REPORTS FOURTH QUARTER AND FULL YEAR 2010 FINANCIAL RESULTS"
02/28/2011 8-K Form 8-K - Current report
11/12/2010 8-K Form 8-K - Current report
11/09/2010 8-K Form 8-K - Current report
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy